Coronavirus: How worried should we be about the Omicron variant?

Omicron’s mutations are likely to render certain COVID-19 treatments – including some manufactured antibodies – ineffective…
Read More

Check Also

Sensex, Nifty create 4% this week; right here’s what drove the rebound?

Sensex, Nifty create 4% this week; right here’s what drove the rebound?

While analysts feel the elementary backdrop has no longer tremendously changed, a combination of home …

Leave a Reply

Your email address will not be published.